Patient-Derived Xenograft / PDX Model Market Set for Expansion as...

added article Home

2024-12-04 11:01:47 -

Patient-Derived Xenograft / PDX Model Market Set for Expansion as Oncology Research Advances, Expected to Reach USD 818 Million by 2030 | Intent Market Research

Patient-Derived Xenograft (PDX) Model Market: Pioneering Advancements in Personalized Medicine The Patient-Derived Xenograft (PDX) Model Market is rapidly expanding as the demand for personalized and precise oncology treatments continues to grow. Valued at USD 356 million in 2023, the market is projected to reach USD 818 million by 2030, reflecting a robust CAGR of...

0 Comments 0 Shares 21 Views 0 Reviews